NextPlat Corp. (NASDAQ:NXPL – Get Free Report) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 5,209 shares, a decline of 31.9% from the June 30th total of 7,645 shares. Based on an average daily volume of 39,473 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.4% of the company’s stock are short sold.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on NXPL. Litchfield Hills Research began coverage on NextPlat in a research note on Wednesday, June 24th. They issued a “buy” rating and a $11.00 price objective for the company. Zacks Research raised shares of NextPlat to a “hold” rating in a research report on Thursday, June 25th. Finally, Weiss Ratings raised shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $11.00.
Check Out Our Latest Stock Analysis on NextPlat
NextPlat Trading Down 1.9%
NextPlat (NASDAQ:NXPL – Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.The firm had revenue of $9.86 million for the quarter. On average, research analysts forecast that NextPlat will post -0.55 EPS for the current fiscal year.
Institutional Investors Weigh In On NextPlat
A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC acquired a new stake in NextPlat Corp. (NASDAQ:NXPL – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat as of its most recent filing with the SEC. 1.30% of the stock is currently owned by hedge funds and other institutional investors.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Further Reading
- Five stocks we like better than NextPlat
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
- MarketBeat Week in Review – 07/27- 07/31
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
